Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma

Jonathon B. Cohen, Madhusmita Behera, Carrie A. Thompson, Christopher R. Flowers

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Up to 50% of patients with Hodgkin lymphoma and diffuse large B-cell lymphoma will relapse, requiring additional therapy. Although surveillance imaging is commonly performed in clinical practice, its ability to identify asymptomatic relapses and improve survival for patients is not well defined. We evaluated the surveillance imaging role in relapse detection and reviewed its impact on survival for relapsed patients, and found that current imaging approaches do not detect most relapses prior to clinical signs and symptoms or improve survival.

Original languageEnglish (US)
Pages (from-to)561-564
Number of pages4
JournalBlood
Volume129
Issue number5
DOIs
StatePublished - Feb 2 2017

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this